{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Merck", "item": "https://www.patentleaderboard.com/2021/company/merck"}, {"@type": "ListItem", "position": 4, "name": "Christopher Moyes", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ch_ln:moyes-5"}]}

Home › 2021 › Merck › Christopher Moyes

Christopher Moyes — 1 Patent in 2021

Merck: 1 patents #304 of 909Top 35%

Westfield, NJ: #33 of 77 inventorsTop 45%

New Jersey: #2,278 of 6,977 inventorsTop 35%

Overall (2021): #497,382 of 548,734Top 95%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11041009	Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes	Danqing Feng, Pei Huo, Ahmet Kekec, Songnian Lin, Ravi Nargund +4 more	2021-06-22	$110,392,000

Christopher Moyes — 1 Patent in 2021

Issued Patents 2021

Patent Widget